Factors that influence the uptake of human papillomavirus vaccine among preadolescent girls in South Africa: A Scoping Review

Boitumelo P. Mokwena, Rodwell Gundo, Fhumulani M. Mulaudzi

Abstract

Human papillomavirus (HPV) infection is a sexually transmitted infection which causes cancer, especially cervical cancer. HPV infection and cervical cancer are a public health concern in South Africa. Primary prevention interventions, such as vaccination against cervical cancer, have been rolled out in the country. However, the uptake of the vaccine faces challenges due to various factors. The aim of the review was to identify factors which influence the uptake of the vaccine. A six-step framework developed by Levac, Colquhon and O’Brien was adopted to guide this scoping review. The articles were searched in the following databases: EBSCOhost, PubMed, CINAHL and Google scholar. The search, conducted from May to July 2023 was limited to articles published in English between 2008-2023 and those conducted in Africa. The results showed that most studies were conducted in sub-Saharan Africa, with majority of the studies being from Nigeria. Subthemes were extracted from the articles and categorised under the four themes of the Social Ecological Model. The four themes used from the Social Ecological Model were individual factors; interpersonal factors; community and societal factors, and organisational factors and public policy. The subthemes were socioeconomic and sociodemographic of parents, knowledge, fear and mistrust, family structure and proximity to cancer/STI, misinformation from social media, religion, culture and tradition, free vaccination programme and lack of engagement. The identified gap in literature was a lack of studies of factors which influence HPV vaccination uptake in South Africa and qualitative studies that explore and provide the factors influencing uptake. We conclude that in designing effective interventions for the uptake of HPV vaccines, it is important to consider influential factors that are tailor-made for specific demographics.

Full Text:

PDF

References

Mbulawa ZZ, Van Schalkwyk C, Hu NC, Meiring TL,

Barnabas S, Dabee S, Jaspan H, Kriek JM, Jaumdally

SZ, Muller E and Bekker LG. 2018. High human

papillomavirus (HPV) prevalence in South African

adolescents and young women encourages expanded

HPV vaccination campaigns. PloS one 2018;13(1),

p.e0190166.

Vinodhini K, Shanmughapriya S, Das BC and

Natarajaseenivasan, K. Prevalence and risk factors of

HPV infection among women from various provinces

of the world. Archives of gynaecology and obstetrics

;285, pp.771-777.

Kombe Kombe AJ, Li B, Zahid A, Mengist HM, Bounda GA,

Zhou Y and Jin T. Epidemiology and burden of human

papillomavirus and related diseases, molecular

pathogenesis, and vaccine evaluation. Frontiers in

public health 2021;8, p.552028.

Mihretie GN, Liyeh TM, Ayele AD, Belay HG, Yimer TS and

Miskr AD. Knowledge and willingness of parents

towards child girl HPV vaccination in Debre Tabor

Town, Ethiopia: a community-based cross-sectional

study. Reproductive Health 2022;19(1), pp.1-12.

Ngcobo NJ, Burnett RJ, Copper S and WIysonge CS. Human

papillomavirus vaccination acceptance and hesitancy

in South Africa: Research and policy agenda. South

African Medical Journal 2019;109(1), pp.13-15.

National Department of Health. Cervical Cancer Prevention

and Control Policy. 2021. doi:

https://www.health.gov.za/wpcontent/uploads/2021/07/cervical-cancer-policy.pdf

Dike SN. Factors associated with African American mothers’

perceptions of human papillomavirus vaccination of

their daughters: An integrated literature

review. Number 4/July 2021;48(4), pp.371-389.

Ledibane TD, Ledibane NR and Matlala M. Performance of

the school-based human papillomavirus vaccine

uptake in Tshwane, South Africa. Southern African

Journal of Infectious Diseases, 2023;38(1), pp.1-6.

Levac D, Colquhoun H and O'Brien KK. Scoping studies:

advancing the methodology. Implementation

science, 2010;5, pp.1-9.

Munn Z, Peters MD, Stern C, Tufanaru C, McArthur A and

Aromataris E. Systematic review or scoping review?

Guidance for authors when choosing between a

systematic or scoping review approach. BMC medical

research methodology, 2018;18, pp.1-7.

Mabeya H, Menon S, Weyers S, Naanyu V, Mwaliko E,

Kirop E, Orango O, Vermandere H and Vanden

Broeck D. Uptake of three doses of HPV vaccine by

primary school girls in Eldoret, Kenya; a prospective

cohort study in a malaria endemic setting. BMC

cancer, 2018;18(1), pp.1-7.

Essoh TA, Adeyanju GC, Adamu AA, Tall H, Aplogan A

and Tabu C. Exploring the factors contributing to low

vaccination uptake for nationally recommended

routine childhood and adolescent vaccines in

Kenya. BMC Public Health, 2023;23(1), pp.1-10.

Mphuru A, Li AJ, Kyesi F, Mwengee W, Mazige F, Nshunju

R, Shayo B, Giattas MR, Loharikar A and Lyimo D.

National introduction of human papillomavirus

(HPV) vaccine in Tanzania: Programmatic decisionmaking and implementation. Vaccine, 2022;40,

pp.A2-A9.

Kisaakye E, Namakula J, Kihembo C, Kisakye A, Nsubuga

P and Babirye JN. Level and factors associated with uptake of human papillomavirus infection vaccine

among female adolescents in Lira District,

Uganda. Pan African Medical Journal, 2018;31(1).

Isabirye A, Mbonye M, Asiimwe JB and Kwagala B. Factors

associated with HPV vaccination uptake in Uganda: a

multi-level analysis. BMC Women's

Health, 2020;20(1), pp.1-11.

Rabiu KA, Alausa TG, Akinlusi FM, Davies NO, Shittu KA

and Akinola OI. Parental acceptance of human

papillomavirus vaccination for adolescent girls in

Lagos, Nigeria. Journal of Family Medicine and

Primary Care, 2020;9(6), p.2950.

Adejuyigbe FF, Balogun BR, Sekoni AO and Adegbola AA.

Cervical cancer and human papilloma virus

knowledge and acceptance of vaccination among

medical students in Southwest Nigeria. African

journal of reproductive health, 2015;19(1), pp.140-

Turiho AK, Okello ES, Muhwezi WW, Byakika-Kibwika P,

Meya D and Katahoire AR. Effect of school-based

human papillomavirus (hpv) vaccination on

adolescent girls' knowledge and acceptability of the

HPV vaccine in Ibanda District in Uganda. African

journal of reproductive health, 2014;18(4), pp.45-53.

Oluwole EO, Idowu OM, Adejimi AA, Balogun MR and

Osanyin GE. Knowledge, attitude and uptake of

human papillomavirus vaccination among female

undergraduates in Lagos State, Nigeria. Journal of

family medicine and primary care, 2019;8(11),

p.3627.

Nabirye J, Okwi LA, Nuwematsiko R, Kiwanuka G, Muneza

F, Kamya C and Babirye JN. Health system factors

influencing uptake of Human Papilloma Virus (HPV)

vaccine among adolescent girls 9-15 years in Mbale

District, Uganda. BMC public health, 2020;20, pp.1-

Elebiyo OT. Knowledge, attitude, and uptake of Human

Papilloma Virus (HPV) vaccine among parents of

adolescents attending outpatient clinic at the

University of Benin Teaching Hospital,

Nigeria. African Journal of Reproductive

Health, 2023;27(3).

Ramathuba DU and Ngambi D. Knowledge and attitudes of

women towards human papilloma virus and HPV

vaccine in Thulamela municipality of Vhembe district

in Limpopo province, South Africa. African Journal

of Reproductive Health, 2018;22(3), pp.111-119.

Beyen MWM, Bulto GA, Chaka EE, Debelo BT, Roga EY,

Wakgari N, Danusa KT and Fekene DB. Human

papillomavirus vaccination uptake and its associated

factors among adolescent school girls in Ambo town,

Oromia region, Ethiopia, 2020. PloS one, 2022;17(7),

p.e0271237.

LaMontagne DS, Manangazira P, Marembo J, Chigodo C,

Zvamashakwe C, Tshuma E, Marima E, Chindedza K,

Ndlela E and Mooney J. HPV vaccination coverage in

three districts in Zimbabwe following national

introduction of 0, 12-month schedule among 10- to

-year-old girls. Vaccine, 2022;40, pp. A58-A66.

Li AJ, Manzi F, Kyesi F, Makame Y, Mwengee W, Fleming

M, Mkopi A, Mmbaga S, Lyimo D and Loharikar A.

Tanzania’s human papillomavirus (HPV) vaccination

program: Community awareness, feasibility, and

acceptability of a national HPV vaccination program,

Vaccine, 2022;40, pp.A38-A48.

Adeyanju GC, Betsch C, Adamu AA, Gumbi KS, Head MG,

Aplogan A, Tall H and Essoh TA. Exploring the

Drivers of Vaccine Hesitancy Toward Childhood and

Adolescent Vaccination in Malawi: A Qualitative

Study. 2021.

Moucheraud C, Whitehead HS, Songo J, Szilagyi PG,

Hoffman RM and Kaunda-Khangamwa BN.

Malawian caregivers’ experiences with HPV

vaccination for preadolescent girls: A qualitative

study. Vaccine: X, 2023;14, p.100315.

Ezeanochie MC and Olagbuji BN. Human papilloma virus

vaccine: determinants of acceptability by mothers for

adolescents in Nigeria. African Journal of

Reproductive Health, 2014;18(3), pp.154-158.

Egbon M, Ojo T, Aliyu A and Bagudu ZS. Challenges and

lessons from a school-based human papillomavirus

(HPV) vaccination program for adolescent girls in a

rural Nigerian community. BMC Public

Health, 2022;22(1), pp.1-8.

Adeyanju GC, Sprengholz P, Betsch C and Essoh T.A.

Caregivers’ willingness to vaccinate their children

against childhood diseases and human

papillomavirus: a cross-sectional study on vaccine

hesitancy in Malawi. Vaccines, 2021;9(11), p.1231.

Akinleye, H.W., Kanma-Okafor, O.J., Okafor, I.P. and

Odeyemi, K.A., 2020. Parental willingness to

vaccinate adolescent daughters against human

papilloma virus for cervical cancer prevention in

Western Nigeria. Pan African Medical

Journal, 36(1).

Olaniyan A, Isiguzo C and Hawk M. The Socioecological

Model as a framework for exploring factors

influencing childhood immunization uptake in Lagos

state, Nigeria. BMC Public Health, 2021;21(1), p.867.

Ndinda C, Ndhlovu T and Khalema NE. Conceptions of

contraceptive use in rural KwaZulu-Natal, South

Africa: lessons for programming. International

journal of environmental research and public

health, 2017;14(4), p.353.

Eaton LA and Kalichman SC. Social and behavioral health

responses to COVID-19: lessons learned from four

decades of an HIV pandemic. Journal of behavioral

medicine, 2020;43, pp.341-345.

Ackah BB, Woo M, Stallwood L, Fazal ZA, Okpani A, Ukah

UV and Adu PA. COVID-19 vaccine hesitancy in

Africa: a scoping review. Global Health Research and

Policy, 2022;7(1), pp.1-20.

Akinleye HW, Kanma-Okafor OJ, Okafor IP and Odeyemi

KA. Parental willingness to vaccinate adolescent

daughters against human papilloma virus for cervical

cancer prevention in Western Nigeria. Pan African

Medical Journal, 2020;36(1).

Ohonba A, Ngepah N and Simo-Kengne B. Maternal

education and child health outcomes in South Africa:

A panel data analysis. Development Southern

Africa, 2019;36(1), pp.33-49.

Makoka D and Masibo PK. Is there a threshold level of

maternal education sufficient to reduce childundernutrition? Evidence from Malawi, Tanzania and

Zimbabwe. BMC pediatrics, 2015;15(1), pp.1-10.

Hofstetter AM and Rosenthal SL. Factors impacting HPV

vaccination: lessons for health care

professionals. Expert review of vaccines, 2014;13(8),

pp.1013-1026.

Remes P, Selestine V, Changalucha J, Ross DA, Wight D,

de Sanjosé S, Kapiga S, Hayes RJ and Watson-Jones

D. A qualitative study of HPV vaccine acceptability

among health workers, teachers, parents, female

pupils, and religious leaders in northwest

Tanzania. Vaccine, 2012;30(36), pp.5363-5367.

Hoque ME, Monokoane S and Van Hal G. Knowledge of

and attitude towards human papillomavirus infection

and vaccines among nurses at a tertiary hospital in

South Africa. Journal of Obstetrics and

Gynaecology, 2014;34(2), pp.182-186.

Amponsah-Dacosta E, Blose N, Nkwinika VV and

Chepkurui V. Human papillomavirus vaccination in

South Africa: programmatic challenges and

opportunities for integration with other adolescent

health services? Frontiers in Public Health, 2022;10,

p.799984.

Watson-Jones D, Mugo N, Lees S, Mathai M, Vusha S,

Ndirangu G and Ross DA. Access and attitudes to

HPV vaccination amongst hard-to-reach populations

in Kenya. PLoS One, 2015;10(6), p.e0123701.

Refbacks

  • There are currently no refbacks.